A positive margin means cancer cells were found right at the cut edge of the tissue removed during surgery.It appears in the histopathology report, and it’s often the single line patients worry about most.It doesn’t automatically mean the cancer has spread or come back. It means the surgeon can’t be sure every cancer cell was removed.
What happens next depends on the cancer type, which edge is involved and how much of it is affected.
According to Prof. Dr. Sandeep Nayak, a surgical oncologist who reviews surgical margins on pathology reports after every resection, “A positive margin is a finding, not a verdict. It tells us where to look more carefully. Sometimes we go back and take more tissue. Sometimes radiation or close follow up is the better answer. The mistake is treating every positive margin the same way.”
Holding a pathology report with the words “positive margin” on it?
How Are Surgical Margins Reported on a Pathology Report?
The pathologist inks the outer surface of the removed tissue, then checks under the microscope how close the cancer comes to it.
Positive: Cancer cells touch the inked edge. Some disease may still be left behind in the body.
Close: Cancer cells sit near the edge without touching it. How near counts as too near varies by cancer type.
Clear: No cancer cells at the edge. This suggests the whole tumour was taken out.
Focal or extensive: A tiny spot of involvement is handled differently from cancer reaching the edge in several places.
Which edge is involved matters as much as the label, so the report is read alongside the operation notes. Our page on surgical oncology consultation covers how that review is done.
What Happens After a Positive Margin?
There isn’t one standard answer. The options below are weighed against each other.
Re-excision: A second operation to remove more tissue from the involved edge. It’s common after breast conserving surgery, where a positive margin roughly doubles the risk of local recurrence.
Radiation: In selected breast cases with a small, focal positive margin, an extra radiation dose to the surgical site may be used instead of another operation.
Close monitoring: Some situations start with scans and tests rather than surgery. After partial nephrectomy, for example, surveillance is often the first step.
Tumour board review: Margin status, tumour type and grade are discussed together. Re-excision isn’t routine for every patient, and research supports a selective approach.
The basics, including what a margin is and how wide it should be, are covered in our blog on what a surgical margin is in cancer surgery.
Why Choose Prof. Dr. Sandeep Nayak for Cancer Surgery and Margin Review in Bangalore?
Prof. Dr. Sandeep Nayak has over 24 years in surgical oncology, with a working focus on complete tumour removal. DNB in Surgical Oncology and General Surgery. MRCS from the UK. A fellowship in Laparoscopic and Robotic Onco Surgery too. He chairs Oncology Services across Karnataka and serves as Executive Director of Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. Every case goes to the tumour board, where surgery notes, pathology and imaging are read together before any next step is chosen.
A positive margin calls for a clear plan, not a rushed one. Patients are walked through what the report says and what each option would mean for them. Call +91 9482202240 to book your consultation.
Frequently Asked Questions
Does a positive margin mean the cancer has spread?
Not necessarily. It means cancer cells reached the cut edge, not that they’ve spread.
Will a positive margin need another surgery?
Often, but not always. It depends on cancer type, location and extent.
What is the difference between a positive and a close margin?
Positive means cancer touches the edge. Close means it’s near but not touching.
Does a positive margin raise recurrence risk?
Yes, it can. That’s why further treatment is usually considered.
References
- National Center for Biotechnology Information — Preoperative Localization and Surgical Margins in Conservative Breast Surgery: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748755/
- National Center for Biotechnology Information — Effect of Re-excision on Local Recurrence in Patients With Involved or Close Margins After Upfront Breast-Conserving Surgery: A Systematic Review and Meta-Analysis: https://pmc.ncbi.nlm.nih.gov/articles/PMC12023596/
Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

